Clearside Biomedical Initiates Chapter 11 Bankruptcy Proceedings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 24 2025
0mins
Source: SeekingAlpha
Bankruptcy Filing: Clearside Biomedical filed for voluntary Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware on November 24, 2025.
Strategic Sale Process: The company is pursuing a structured Chapter 11 process to conduct an auction and sale of its business, aiming to maximize stakeholder value.
Stock Price Decline: Following the bankruptcy announcement, Clearside's stock price dropped approximately 70%, reaching $0.82 during pre-market trading.
Asset Acquisition: Interested parties will have the opportunity to submit binding offers to acquire Clearside's assets free of liens and interests as part of the bankruptcy proceedings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
